Collectively, these findings provided the important mechanism of SLC7A2-mediated tumor immune evasion through attracting MDSCs and put forth blockage of MDSCs recruitment as a prospective immunotherapy strategy for the treatment of SLC7A2 deficiency HCC metastasis. Here, SLC7A2 is linked to hepatocellular carcinoma.